Table 3 Outcome of the pediatric CBF AML patient population
CBF | inv(16) | t(8;21) | P | ||||
|---|---|---|---|---|---|---|---|
% | 95%CI | % | 95%CI | % | 95%CI | ||
CR | 95.2 | 94 | 95.9 | 0.441 | |||
CIR | |||||||
Median, years | 3.9 | 3.6 | 4.1 | ||||
10 years | 29.4 | 24.9–33.9 | 35.2 | 27.9–42.6 | 25.4 | 19.9–31.2 | 0.026 |
OS | |||||||
Median, years | 4.9 | 5.2 | 4.6 | ||||
10 years | 84.4 | 80.5–88.5 | 89.5 | 84.7–94.6 | 80.7 | 75.1–86.8 | 0.027 |